BioLineRx Ltd. (BLRX)
0.10
-0.01 (-8.76%)
At close: Jan 29, 2025, 3:59 PM
0.10
0.67%
After-hours Jan 29, 2025, 07:48 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 |
| PE Ratio | -1.72 | -1.66 | -3.27 | -1.4 | -0.85 | -2.06 | -4.03 | -3.27 | -4.69 | -5.26 | -3.6 | -2.09 | -2.87 | 53.38 |
| PS Ratio | 21.70 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.51 |
| PB Ratio | 7.88 | 0.68 | 1.35 | 1.97 | 0.68 | 1.15 | 1.85 | 1.48 | 1.42 | 1.68 | 5.44 | 2.85 | 1.68 | n/a |
| P/FCF Ratio | -4.55 | -1.3 | -3.89 | -1.87 | -1 | -1.38 | -3.96 | -3.56 | -4 | -3.65 | -3.12 | -2.1 | -3.29 | 10.36 |
| P/OCF Ratio | -4.61 | -1.32 | -3.91 | -1.87 | -1 | -1.96 | -4.77 | -3.57 | -4.76 | -3.7 | -3.14 | -2.12 | -3.37 | 9.76 |
| OCF/S Ratio | -4.71 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.36 |
| Debt / Equity Ratio | 0.88 | 0.24 | 0.07 | 0.35 | 0.31 | 0.21 | 0.00 | 0.01 | 0.01 | n/a | n/a | 0.00 | 0.00 | n/a |
| Quick Ratio | 1.47 | 4.85 | 5.89 | 2.14 | 2.35 | 4.74 | 14.05 | 9.86 | 28.69 | 12.11 | 6.26 | 3.45 | 4.02 | n/a |
| Current Ratio | 1.53 | 4.87 | 5.91 | 2.15 | 2.36 | 4.74 | 7.49 | 9.86 | 15.34 | 12.10 | 6.26 | 3.45 | 4.02 | n/a |
| Asset Turnover | 0.08 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Interest Coverage | -23.18 | -13.51 | -25.18 | -15.6 | -15.37 | -1.22K | -1.20K | -1.18K | -1.08K | -38.5 | -852.57 | -840.79 | -13.76 | 222.70 |
| Return on Equity (ROE) | -4.58 | -0.41 | -0.41 | -1.4 | -0.8 | -0.56 | -0.46 | -0.45 | -0.3 | -0.32 | -1.51 | -1.36 | -0.59 | n/a |
| Return on Assets (ROA) | -0.95 | -0.27 | -0.35 | -0.65 | -0.5 | -0.41 | -0.4 | -0.41 | -0.28 | -0.28 | -0.88 | -0.84 | -0.45 | n/a |
| Return on Capital (ROIC) | -1.5 | -0.44 | -0.35 | -0.63 | -0.68 | -0.52 | -0.47 | -0.47 | -0.34 | -0.48 | -1.04 | -1.22 | -0.68 | n/a |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 23.08% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 77.40% |
| Net Profit Margin | -1.26K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 6.57% |
| Pretax Profit Margin | -1.26K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 6.57% |
| Operating Profit Margin | -1.04K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 11.61% |
| FCF Margin | -477.19% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -17.98% | -17.93% | -18.01% | 33.87% |
| EBITDA Margin | -1.19K% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -14.76% | -17.13% | -21.26% | 13.21% |